TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $620,000 | +4.7% | 5,502 | +4.1% | 0.00% | 0.0% |
| Q2 2017 | $592,000 | -6.0% | 5,284 | -11.7% | 0.00% | 0.0% |
| Q4 2016 | $630,000 | -19.5% | 5,984 | -15.5% | 0.00% | 0.0% |
| Q3 2016 | $783,000 | -25.1% | 7,084 | -1.4% | 0.00% | -50.0% |
| Q2 2016 | $1,046,000 | +118.4% | 7,184 | +112.3% | 0.00% | – |
| Q1 2016 | $479,000 | -49.2% | 3,384 | -44.5% | 0.00% | -100.0% |
| Q4 2015 | $943,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |